Home › NDC Lookup › RxCUI directory › RxCUI 1011485

Cetirizine hydrochloride 10 MG Disintegrating Oral Tablet [Zyrtec] — RxCUI 1011485

RxNorm drug concept · Semantic branded drug
RxCUI 1011485 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1011485
Official nameCetirizine hydrochloride 10 MG Disintegrating Oral Tablet [Zyrtec]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZyrtec 10 MG Disintegrating Oral Tablet
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cetirizine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zerviate is an antihistamine eye drop that treats itchy eyes caused by allergic conjunctivitis — basically, eye allergies. It works right where you need it, blocking the itch signa...
  • You need to take your contacts out first. The preservative in Zerviate can get soaked up by soft contact lenses, which isn't good for your eyes. After you put the drops in, wait at...
  • Can I put my contact lenses in before or after using these drops?
  • The most common ones are eye redness, a brief sting or pain when the drop goes in, and slightly blurry vision right after. These are usually mild and short-lived. If you notice wor...
📖 Read our full Cetirizine Ophthalmic guide →

🕸️ Concept Web — How Cetirizine hydrochloride 10 MG Disintegrating Or... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cetirizine hydrochloride 10 MG Disintegrating Oral Tablet [Zyrtec] RxCUI 1011485

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Cetirizine 20610
    • Cetirizine hydrochloride 203150
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zyrtec 58930
  3. Dose forms 17

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cetirizine Disintegrating Oral Tablet 1011481
    • Cetirizine hydrochloride Disintegrating Oral Tablet 2648544
    • Cetirizine Disintegrating Oral Product 1295004
    • Cetirizine Oral Product 1152446
    • Cetirizine Pill 1152447
    • Cetirizine hydrochloride Disintegrating Oral Product 2662664
    • Cetirizine hydrochloride Oral Product 2661571
    • Cetirizine hydrochloride Pill 2661620
    • +9 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cetirizine hydrochloride 10 MG Disintegrating Oral Tablet SCD · 1011482
  • Cetirizine hydrochloride 10 MG SCDC · 1011480
  • Cetirizine Disintegrating Oral Tablet SCDF · 1011481
  • Cetirizine hydrochloride Disintegrating Oral Tablet SCDFP · 2648544
  • Cetirizine Disintegrating Oral Product SCDG · 1295004
  • Cetirizine Oral Product SCDG · 1152446
  • Cetirizine Pill SCDG · 1152447
  • Cetirizine hydrochloride Disintegrating Oral Product SCDGP · 2662664
  • Cetirizine hydrochloride Oral Product SCDGP · 2661571
  • Cetirizine hydrochloride Pill SCDGP · 2661620

Brand-Name Concepts

  • Cetirizine hydrochloride 10 MG [Zyrtec] SBDC · 1011483
  • Cetirizine Disintegrating Oral Tablet [Zyrtec] SBDF · 1011484
  • Cetirizine hydrochloride Disintegrating Oral Tablet [Zyrtec] SBDFP · 2657595
  • Zyrtec Disintegrating Oral Product SBDG · 1296197
  • Zyrtec Oral Product SBDG · 1186678
  • Zyrtec Pill SBDG · 1186679
  • Zyrtec BN · 58930

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 1011485 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50580-0778-24 4 BLISTER PACK in 1 CARTON (50580-778-24) / 6 TABLET, ORALL... Zyrtec Allergy Kenvue Brands LLC 2014-01-20
50580-0782-01 2 CARTON in 1 PACKAGE (50580-782-01) / 4 BLISTER PACK in 1... Childrens Zyrtec Allergy Kenvue Brands LLC 2014-01-20
50580-0782-12 2 BLISTER PACK in 1 CARTON (50580-782-12) / 6 TABLET, ORALL... Childrens Zyrtec Allergy Kenvue Brands LLC 2014-01-20
50580-0782-24 4 BLISTER PACK in 1 CARTON (50580-782-24) / 6 TABLET, ORALL... Childrens Zyrtec Allergy Kenvue Brands LLC 2014-01-20
Observed labelers: Kenvue Brands LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.